These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36539667)
1. Reduction in ABCG2 mRNA Expression in Human Immortalised Brain Microvascular Endothelial Cells by Ferric Ammonium Citrate is Mediated by Reactive Oxygen Species and Activation of ERK1/2 Signalling. Newman SA; Short JL; Nicolazzo JA Pharm Res; 2023 Mar; 40(3):651-660. PubMed ID: 36539667 [TBL] [Abstract][Full Text] [Related]
2. Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells. Newman SA; Pan Y; Short JL; Nicolazzo JA Pharm Res; 2021 Jan; 38(1):97-111. PubMed ID: 33532991 [TBL] [Abstract][Full Text] [Related]
3. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374 [TBL] [Abstract][Full Text] [Related]
4. Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation. Li Y; Zhang J; Xu P; Sun B; Zhong Z; Liu C; Ling Z; Chen Y; Shu N; Zhao K; Liu L; Liu X J Neurochem; 2016 Jul; 138(2):282-94. PubMed ID: 27168176 [TBL] [Abstract][Full Text] [Related]
5. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Poller B; Drewe J; Krähenbühl S; Huwyler J; Gutmann H Cell Mol Neurobiol; 2010 Jan; 30(1):63-70. PubMed ID: 19629677 [TBL] [Abstract][Full Text] [Related]
6. A Combination of Clioquinol, Zinc and Copper Increases the Abundance and Function of Breast Cancer Resistance Protein in Human Brain Microvascular Endothelial Cells. Yap C; Short JL; Nicolazzo JA J Pharm Sci; 2021 Jan; 110(1):338-346. PubMed ID: 32339529 [TBL] [Abstract][Full Text] [Related]
7. Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells. Lye P; Bloise E; Imperio GE; Chitayat D; Matthews SG Cells; 2022 Jul; 11(14):. PubMed ID: 35883702 [TBL] [Abstract][Full Text] [Related]
8. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier. Hoque MT; Shah A; More V; Miller DS; Bendayan R J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636 [TBL] [Abstract][Full Text] [Related]
9. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Daood M; Tsai C; Ahdab-Barmada M; Watchko JF Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709 [TBL] [Abstract][Full Text] [Related]
10. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Lee G; Babakhanian K; Ramaswamy M; Prat A; Wosik K; Bendayan R Pharm Res; 2007 Jul; 24(7):1262-74. PubMed ID: 17380269 [TBL] [Abstract][Full Text] [Related]
11. Iron Reduces the Trafficking of Fatty Acids from Human Immortalised Brain Microvascular Endothelial Cells Through Modulation of Fatty Acid Transport Protein 1 (FATP1/SLC27A1). Supti ST; Koehn LM; Newman SA; Pan Y; Nicolazzo JA Pharm Res; 2024 Aug; 41(8):1631-1648. PubMed ID: 39044044 [TBL] [Abstract][Full Text] [Related]
12. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Eisenblätter T; Hüwel S; Galla HJ Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238 [TBL] [Abstract][Full Text] [Related]
14. Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats. Mairinger S; Hernández-Lozano I; Filip T; Sauberer M; Löbsch M; Stanek J; Wanek T; Sake JA; Pekar T; Ehrhardt C; Langer O J Control Release; 2022 Sep; 349():109-117. PubMed ID: 35798092 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma. Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687 [TBL] [Abstract][Full Text] [Related]
16. Chorioamnionitis Induces a Specific Signature of Placental ABC Transporters Associated with an Increase of miR-331-5p in the Human Preterm Placenta. do Imperio GE; Bloise E; Javam M; Lye P; Constantinof A; Dunk C; Dos Reis FM; Lye SJ; Gibb W; Ortiga-Carvalho TM; Matthews SG Cell Physiol Biochem; 2018; 45(2):591-604. PubMed ID: 29402780 [TBL] [Abstract][Full Text] [Related]
17. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. Poller B; Gutmann H; Krähenbühl S; Weksler B; Romero I; Couraud PO; Tuffin G; Drewe J; Huwyler J J Neurochem; 2008 Dec; 107(5):1358-68. PubMed ID: 19013850 [TBL] [Abstract][Full Text] [Related]
18. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220 [TBL] [Abstract][Full Text] [Related]
19. Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies. Zhou Y; Zhou J; Li P; Xie Q; Sun B; Li Y; Chen Y; Zhao K; Yang T; Zhu L; Xu J; Liu X; Liu L Eur J Pharmacol; 2019 Mar; 846():119-127. PubMed ID: 30639310 [TBL] [Abstract][Full Text] [Related]
20. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration. Gonçalves J; Silva S; Gouveia F; Bicker J; Falcão A; Alves G; Fortuna A Int J Pharm; 2021 Jan; 593():120161. PubMed ID: 33307160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]